期刊文献+

下调CACNA2D1对胃癌耐药细胞系SGC7901/ADR药物敏感性的影响 被引量:1

The effect of CACNA2D1 on drug resistance in gastric cancer cell line SGC7901/ADR
在线阅读 下载PDF
导出
摘要 目的:探讨下调CACNA2D1对胃癌耐药性细胞系SGC7901/ADR耐药的影响。方法:采用实时荧光定量聚合酶链反应(qRT-PCR)的方法检测16对胃癌及癌旁组织以及胃癌细胞系SGC7901和SGC7901/ADR中的CACNA2D1的mRNA表达水平;蛋白免疫印迹技术(Western blot)检测CACNA2D1的蛋白表达情况;MTT法检测SGC7901、SGC7901/ADR及转染CACNA2D1 siRNA后SGC7901/ADR的IC50值;流式细胞仪检测细胞凋亡。结果:qRT-PCR结果显示:CACNA2D1在胃癌组织中的表达明显高于癌旁组织(P<0.01);CACNA2D1在耐药细胞系SGC7901/ADR中的表达明显高于其亲本细胞系SGC7901(P<0.01)。蛋白免疫印迹技术结果显示相对于转染CACNA2D1 negative control(NC)组,转染CACNA2D1 siRNA组的胃癌细胞CACNA2D1表达降低;MTT结果显示细胞系SGC 7901与SGC7901/ADR的阿霉素半数抑制浓度(IC50)分别为(1.3±0.6)μg/ml与(5.5±0.45)μg/ml;SGC7901/ADR转染CACNA2D1 siRNA后对阿霉素的IC50明显下降。流式细胞术检测凋亡结果显示,CACNA2D1的表达下调后,SGC7901/ADR细胞的凋亡比明显增加。结论:CACNA2D1能够促进胃癌SGC7901/ADR细胞系产生多药耐药。 Objective: To investigate the influence of CACNA2D1 knock - down on drug resistance in gastric cancer cell line SGC7901/ADR. Methods:The mRNA levels of CACNA2D1 in SGC7901 ,SGC7901/ADR and 16 pairs of the gastric cancer tissues and adjacent normal tissues were determined by qRT - PCR assays. The influence of CAC- NA2D1 on the IC50 and apoptosis of cell line SGC7901/ADR were evaluated using MTT and FACS assay. Results: CACNA2D1 mRNA levels were upregulated in gastric cancer tissues compared with adjacent normal tissues (P 〈 0.01 ), and the mRNA level of CACNA2D1 in SGC7901/ADR was significantly higher than that in SGC 7901 (P 〈 0.01 ). MTT and FACS assay showed that the muhidrug resistance were reversed by CACNA2D1 knock - down in SGC7901/ADR cells. Conelusion:CACNA2D1 could contribute to the multidrug resistance of gastric cancer cell line SGC7901/ADR.
出处 《现代肿瘤医学》 CAS 2015年第10期1325-1328,共4页 Journal of Modern Oncology
基金 国家自然科学基金资助项目(编号:81301883)
关键词 胃癌 CACNA2D1 多药耐药 gastric cancer CACNA2D1 multidrug resistance
作者简介 王凯(1988一),男,山东潍坊人,医师,硕士研究生,主要从事胃癌的临床与基础研究。E—mail:871883489@qq.com 【通讯作者】樊代明(1953一),男,四川重庆人,中国工程院院士,教授,主任医师,主要从事胃癌的临床与基础研究。E—mail:fandaim@fmmu.edu.cn
  • 相关文献

参考文献16

  • 1Jemal A,Bray F,Center MM,et al. Global cancer statistics[ J]. CACancer J Clin,2011,61 (2) :69 -90.
  • 2Zhang D,Fan D. New insights into the mechanisms of gastric cancermultidrug resistance and future perspectives [ J ]. Future Oncol,2010,6(4):527 -537.
  • 3Zhang D,Fan D. Multidrug resistance in gastric cancer:recent re-search advances and ongoing therapeutic challenges [ J ]. ExpertRev Anticancer Ther,2007,7(10) :1369 -1378.
  • 4Hakomori S. Glycosylation defining cancer malignancy :nevv wine in anold botUe[J]. Proc Natl Acad Sci USA,2002,99 (16): 10231 -10233.
  • 5Christiansen MN’Chik J,Lee L,et al. Cell surface protein glycosy-lation in cancer[ J]. Proteomics,2014,14(4 -5) :525 -546.
  • 6Nagasaka Y,Sano T,Oda K,et al. Impact of genetic deficiencies ofP - glycoprotein and breast cancer resistance protein on pharmaco-kinetics of aripiprazole and dehydroaripiprazole [ J ]. Xenobiotica,2014,44(10):926-932.
  • 7Hale LP,Price DT,Sanchez LM,et al. Zinc alpha-2 - glycoproteinis expressed by malignant prostatic epithelium and may serve as apotential serum marker for prostate cancer [ J ]. Clin Cancer Res,2001,7(4):846 -853.
  • 8Tucker TG,Milne AM,Foumel - Gigleux S,et al. Absolute immu-noquantiiication of the expression of ABC transporters P - glycopro-tein ,breast cancer resistance protein and multidrug resistance - as-sociated protein 2 in human liver and duodenum [ J ]. BiochemPharmacol,2012,83(2) :279 -285.
  • 9Li K,Sun Z,Zheng J,et al. In - depth research of multidrug resist-ance related cell surface ycoproteome in gastric cancer[ J]. J Pro-teomics,2013 ,82 :130 - 140.
  • 10Pauwels EK, Erba P, Mariani G, et al. Multidrug resistance incancer : its mechanism and its modulation [ J ] . Drug News Per-spect,2007,20(6) :371 -377.

引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部